Evolus logo

Evolus share price today

(EOLS)

Evolus share price is $11 & ₹943.91 as on 7 Jan 2025, 2.30 'hrs' IST

$11

-0.53

(-4.6%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Evolus share price in Dollar and Rupees. Guide to invest in Evolus stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Evolus, along with analyst recommendations, forecasts, and comprehensive financials.

Evolus share price movements

  • Today's Low: $10.93
    Today's High: $11.57

    Day's Volatility :5.53%

  • 52 Weeks Low: $9.95
    52 Weeks High: $17.82

    52 Weeks Volatility :44.16%

Evolus Returns

PeriodEvolus, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-30.12%
-8.4%
0.0%
6 Months
3.22%
-3.8%
0.0%
1 Year
11.19%
-0.1%
0.0%
3 Years
93.46%
2.9%
-19.8%

Evolus Key Statistics

in dollars & INR

Previous Close
$11.53
Open
$11.61
Today's High
$11.57
Today's Low
$10.93
Market Capitalization
$699.1M
Today's Volume
$1.2M
52 Week High
$17.82
52 Week Low
$9.95
Revenue TTM
$248.3M
EBITDA
$-26.3M
Earnings Per Share (EPS)
$-0.91
Profit Margin
-22.33%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-861.68%

How to invest in Evolus from India?

It is very easy for Indian residents to invest directly in Evolus from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Evolus stock in both Indian Rupees (INR) and US Dollars (USD). Search for Evolus or EOLS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Evolus or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Evolus shares which would translate to 0.078 fractional shares of Evolus as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Evolus, in just a few clicks!

Returns in Evolus for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Evolus investment value today

Current value as on today

₹1,09,298

Returns

₹9,298

(+9.3%)

Returns from Evolus Stock

₹6,075 (+6.08%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Evolus

36%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Evolus on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 36% more investors are searching Evolus in the last 30 days versus the previous period.

Global Institutional Holdings in Evolus

  • Perceptive Advisors LLC

    8.46%

  • TANG CAPITAL MANAGEMENT LLC

    7.66%

  • BlackRock Inc

    6.33%

  • Vanguard Group Inc

    5.05%

  • Nantahala Capital Management, LLC

    4.46%

  • Caligan Partners LP

    3.46%

Analyst Recommendation on Evolus

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Evolus(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
13
13
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Evolus

What analysts predicted

Upside of 112.99%

Current:

$11.00

Target:

$23.43

Insights on Evolus

  • Price Movement

    In the last 3 months, EOLS stock has moved down by -29.4%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 66.90M → 61.08M (in $), with an average decrease of 8.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -11.35M → -19.17M (in $), with an average decrease of 68.9% per quarter
  • EOLS vs HLN (1 yr)

    In the last 1 year, Haleon Plc Spon Ads has given 12.0% return, outperforming this stock by 1.7%
  • Price to Sales

    ForEOLS every $1 of sales, investors are willing to pay $2.8, whereas for Haleon Plc Spon Ads, the investors are paying $3.9 for every $1 of sales.

Evolus Technicals Summary

Sell

Neutral

Buy

Evolus is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Evolus Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Evolus, Inc.
-5.34%
3.22%
11.19%
93.46%
-0.86%
Neurocrine Biosciences Inc.
6.95%
-3.63%
3.11%
80.66%
21.4%
Haleon Plc Spon Ads
-1.87%
9.87%
9.24%
27.67%
27.67%
Zoetis Inc.
-8.33%
-6.27%
-16.74%
-23.18%
20.92%
Viatris Inc.
-4.06%
13.7%
4.87%
-18.19%
-24.85%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Evolus, Inc.
NA
NA
NA
-0.28
-8.62
-0.1
NA
0.09
Neurocrine Biosciences Inc.
36.83
36.83
0.33
6.37
0.16
0.12
NA
26.87
Haleon Plc Spon Ads
28.91
28.91
1.72
0.34
0.07
0.04
0.02
1.82
Zoetis Inc.
30.57
30.57
2.53
5.88
0.47
0.15
0.01
11.59
Viatris Inc.
224.4
NA
0.08
2.69
-0.04
0.02
0.04
16.58
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Evolus, Inc.
Buy
$699.1M
-0.86%
NA
-22.33%
Neurocrine Biosciences Inc.
Buy
$14.0B
21.4%
36.83
17.21%
Haleon Plc Spon Ads
Buy
$43.1B
27.67%
28.91
10.75%
Zoetis Inc.
Buy
$73.5B
20.92%
30.57
26.55%
Viatris Inc.
Hold
$14.9B
-24.85%
224.4
-5.87%

About Evolus

evolus, inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the united states. it offers jeuveau, a proprietary 900 kilodalton purified botulinum toxin type a formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. the company was founded in 2012 and is headquartered in newport beach, california.
Organization
Evolus
Employees
322
CEO
Mr. David Moatazedi
Industry
Health Technology

Management People of Evolus

NameTitle
Mr. David Moatazedi
President, CEO & Director
Ms. Sandra Beaver
Chief Financial Officer
Dr. Rui Avelar C.CFP, Dip.SportMed, M.D.
Chief Medical Officer and Head of Research & Development
Mr. Nareg Sagherian
Head of Global Investor Relations & Corporate Communications
Mr. Jeffrey J. Plumer
General Counsel
Mr. Kurt Knab
Vice President of Sales
Ms. Tomoko Yamagishi-Dressler
Chief Marketing Officer
Ms. Jessica Novak
Senior Vice President of Human Resources

Important FAQs about investing in Evolus from India :

What is Evolus share price today?

Evolus share price today stands at $11.00, Open: $11.61 ; Previous Close: $11.53 ; High: $11.57 ; Low: $10.93 ; 52 Week High: $17.82 ; 52 Week Low: $9.95. The stock opens at $11.61, after a previous close of $11.53. The stock reached a daily high of $11.57 and a low of $10.93, with a 52-week high of $17.82 and a 52-week low of $9.95.

Can Indians buy Evolus shares?

Yes, Indians can invest in the Evolus (EOLS) from India.

With INDmoney, you can buy Evolus at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Evolus at zero transaction cost.

How can I buy Evolus shares from India?

It is very easy to buy Evolus from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Evolus be purchased?

Yes, you can buy fractional shares of Evolus with INDmoney app.

What are the documents required to start investing in Evolus stocks?

To start investing in Evolus, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Evolus

Today’s highest price of Evolus (EOLS) is $11.57.

Today’s lowest price of Evolus (EOLS) is $10.93.

What is today's market capitalisation of Evolus

Today's market capitalisation of Evolus EOLS is 699.1M

What is the 52 Week High and Low Range of Evolus

  • 52 Week High

    $17.82

  • 52 Week Low

    $9.95

What are the historical returns of Evolus?

  • 1 Month Returns

    -5.34%

  • 3 Months Returns

    3.22%

  • 1 Year Returns

    11.19%

  • 5 Years Returns

    -0.86%

Who is the Chief Executive Officer (CEO) of Evolus

Mr. David Moatazedi is the current Chief Executive Officer (CEO) of Evolus.